Clinical Trial Update: Intervention With n3 LC-PUFA-supplemented Yogurt [NA]

View source ↗

Summary

A completed clinical trial evaluated n3 LC-PUFA–supplemented yogurt in moderately hypertriglyceridemic subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• n3 LC-PUFA-supplemented Yogurt

Snippet

Sponsor: University of Jena | Conditions: Moderate Hypertriacylglycerolemic Subjects | NA | Status: COMPLETED